S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Lucid Group's Buyout Rumors Continue
These AI, Cloud Stocks are Down Significantly, Not For Long
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Dividend King Sysco: Buying On The Dip 
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Wall Street climbs to add more to its strong January
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Lucid Group's Buyout Rumors Continue
These AI, Cloud Stocks are Down Significantly, Not For Long
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Dividend King Sysco: Buying On The Dip 
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Wall Street climbs to add more to its strong January
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Lucid Group's Buyout Rumors Continue
These AI, Cloud Stocks are Down Significantly, Not For Long
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Dividend King Sysco: Buying On The Dip 
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Wall Street climbs to add more to its strong January
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Lucid Group's Buyout Rumors Continue
These AI, Cloud Stocks are Down Significantly, Not For Long
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Dividend King Sysco: Buying On The Dip 
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Wall Street climbs to add more to its strong January
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
NYSE:CNMD

CONMED - CNMD Stock Forecast, Price & News

$95.76
+1.85 (+1.97%)
(As of 01/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$93.51
$95.99
50-Day Range
$79.75
$98.97
52-Week Range
$71.09
$155.51
Volume
468,471 shs
Average Volume
403,514 shs
Market Capitalization
$2.92 billion
P/E Ratio
N/A
Dividend Yield
0.83%
Price Target
$106.00

CONMED MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
10.7% Upside
$106.00 Price Target
Short Interest
Bearish
11.71% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.63mentions of CONMED in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$401,895 Sold Last Quarter
Proj. Earnings Growth
6.98%
From $3.15 to $3.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

794th out of 1,055 stocks

Electromedical Equipment Industry

19th out of 23 stocks


CNMD stock logo

About CONMED (NYSE:CNMD) Stock

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States, Americas excluding the United States, Europe, Middle East, and Africa, and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock News Headlines

CONMED (CNMD) Set to Announce Quarterly Earnings on Thursday
Reviewing CONMED (NYSE:CNMD) & Star Equity (NASDAQ:STRR)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
CONMED Corp.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
ConMed: Still Fairly Priced, Turning More Constructive
CONMED Corporation Announces Quarterly Cash Dividend
Why Is Conmed (CNMD) Up 6.8% Since Last Earnings Report?
CONMED Corp. Withdraws Full-year Guidance
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Company Calendar

Ex-Dividend for 1/5 Dividend
12/15/2022
Dividend Payable
1/05/2023
Today
1/31/2023
Next Earnings (Confirmed)
2/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Employees
3,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$106.00
High Stock Price Forecast
$106.00
Low Stock Price Forecast
$106.00
Forecasted Upside/Downside
+10.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$62.54 million
Pretax Margin
-2.87%

Debt

Sales & Book Value

Annual Sales
$1.01 billion
Cash Flow
$6.28 per share
Book Value
$26.85 per share

Miscellaneous

Free Float
28,988,000
Market Cap
$2.92 billion
Optionable
Optionable
Beta
1.35

Key Executives

  • Curt R. HartmanCurt R. Hartman
    Chairman, President & Chief Executive Officer
  • Todd W. GarnerTodd W. Garner
    Chief Financial Officer & Executive Vice President
  • Shanna L. Cotti-Osmanski
    Chief Information Officer & Executive VP-IT
  • Heather L. Cohen
    EVP, Chief Human Resources & Legal Officer
  • Terence M. Bergé
    Vice President & Controller













CNMD Stock - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price forecast for 2023?

1 analysts have issued 1-year price targets for CONMED's stock. Their CNMD share price forecasts range from $106.00 to $106.00. On average, they anticipate the company's stock price to reach $106.00 in the next twelve months. This suggests a possible upside of 10.7% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2023?

CONMED's stock was trading at $88.64 at the beginning of the year. Since then, CNMD stock has increased by 8.0% and is now trading at $95.76.
View the best growth stocks for 2023 here
.

Are investors shorting CONMED?

CONMED saw a increase in short interest in December. As of December 15th, there was short interest totaling 3,550,000 shares, an increase of 7.3% from the November 30th total of 3,310,000 shares. Based on an average trading volume of 412,700 shares, the days-to-cover ratio is currently 8.6 days.
View CONMED's Short Interest
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our CNMD earnings forecast
.

How can I listen to CONMED's earnings call?

CONMED will be holding an earnings conference call on Thursday, February 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Monday, December 5th. Investors of record on Friday, December 16th will be paid a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 annualized dividend and a yield of 0.84%. The ex-dividend date of this dividend is Thursday, December 15th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.83%.
Read our dividend analysis for CNMD.

What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY 2023 earnings guidance on Thursday, December, 15th. The company provided earnings per share (EPS) guidance of $3.20-$3.50 for the period, compared to the consensus earnings per share estimate of $3.39. The company issued revenue guidance of $1.17 billion-$1.23 billion, compared to the consensus revenue estimate of $1.21 billion.

What is CONMED's stock symbol?

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by a number of retail and institutional investors. Top institutional investors include New York State Common Retirement Fund (0.98%), Congress Asset Management Co. MA (0.55%), Mountain Pacific Investment Advisers Inc. ID (0.41%), Peregrine Capital Management LLC (0.38%), Moody Aldrich Partners LLC (0.17%) and AMI Asset Management Corp (0.16%).
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $95.76.

How much money does CONMED make?

CONMED (NYSE:CNMD) has a market capitalization of $2.92 billion and generates $1.01 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or ($2.95) on an earnings per share basis.

How many employees does CONMED have?

The company employs 3,800 workers across the globe.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.

This page (NYSE:CNMD) was last updated on 2/1/2023 by MarketBeat.com Staff